(1r)-1-(2-Bromo-4-fluorophenyl)ethan-1-ol, 98%, 50mg

(4-Aminophenyl)(4-hydroxyphenyl)methanone, 98%, 100mg

Bromoéthane, min 99,5%, pour synthèse, 2,5 L, emballage verre

4-(4-Carboxyphenyl)piperazine-1-carboxylic acid tert-butyl ester, 95.0%, 10g

Methyl 2-(4-oxopiperidin-1-yl)acetate, 97%, 250mg

Methyl benzo[d][1,3]dioxole-5-carboxylate, 95.0%, 5g

4-Amino-1-(cyclopropylmethyl)pyridin-2(1H)-one, 1g

(trans,trans)-4-(4-Ethoxy-2,3-difluorophenyl)-4'-pentyl-1,1'-bi(cyclohexane), 95.0%, 5g

3-Tetrazol-1-yl-1H-pyrazole-4-carboxylic acid, 95.0%, 5g

trans-4-Isopropylcyclohexanol>93.0%(GC)1g

(1-Ethylcyclopropyl)methanol, 95%, 250mg

3-Phenylpyrrolidin-2-one, 95.0%, 5g

N-(2-Chloroethyl)-imidazole hydrochloride, 97.0%, 1g